A lightweight robotic device has helped children with spinal muscular atrophy (SMA) achieve a ...

Researchers review pulmonary function testing measures that span 4 categories that can assess the respiratory muscle dysfunction that happens in diseases like spinal muscular atrophy (SMA). Muscle ...

New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...

Advanced quantitative EMG monitoring solutions from Senzime are now available through Fukuda Denshi USA to support ...

Simultaneously achieving ultra-softness, ultrahigh sensitivity and mechanical resiliency is a major challenge for wearable electronics and soft machines. The soft yet wearable sensors with their ...

Findings published in The American Journal of Pathology identify GLUD1 enzyme as a potential therapeutic target for muscle restoration through metabolic reprogramming, addressing clinically unmet need ...

UPPSALA, SE / ACCESS Newswire / May 27, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that its TetraGraph® neuromuscular monitoring system has received an additional FDA Class II ...

After nerve injury, the protein complex mTORC1 takes over an important function in skeletal muscle to maintain the neuromuscular junction, the synapse between the nerve and muscle fiber. Researchers ...

Simultaneously achieving ultra-softness, ultrahigh sensitivity and mechanical resiliency is a major challenge for wearable electronics and soft machines. The soft yet wearable sensors with their ...